52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Altria Group Reports Q3 Adjusted Diluted EPS Of $1.22
FDA To Seek More Time To Decide Fate Of Juul - WSJ
Altria Increases Quarterly Dividend By 4.7% To $0.90 Per Share
Altria Group, Inc. is a holding company. The Company's segments include smokeable products, and oral tobacco products. Its subsidiaries include Philip Morris USA Inc. (PM USA), which is engaged in the manufacture and sale of cigarettes in the United States, and John Middleton Co. (Middleton), which is engaged in the manufacture and sale of machine-made cigars and pipe tobacco. Its other operating companies include Philip Morris Capital Corporation, a subsidiary that maintains a portfolio of finance assets. It also owns interest in Helix Innovations LLC, which is engaged in the manufacture and sale of oral nicotine pouches. Other subsidiaries include Altria Group Distribution Company, which provides sales and distribution services to certain its operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas, such as legal, regulatory, consumer engagement, finance, human resources and external affairs to the Company and its subsidiaries.
6601 W Broad St
Kathryn B. Mcquade
Independent Chairman of the Board
William F. Gifford
Chief Executive Officer, Director
Chief Financial Officer, Executive Vice President
Jody L. Begley
Chief Operating Officer, Executive Vice President
Charlie N. Whitaker
Senior Vice President, Chief Human Resources Officer and Chief Compliance Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
A federal judge has allowed most claims to go forward in antitrust litigation by e-cigarette purchasers accusing Juul Labs Inc and Altria Group Inc of working together to suppress competition in the e-cigarette market.
Current and former directors of e-cigarette maker Juul Labs Inc, as well as its largest investor, Altria Group, have lost bids to dismiss 18 bellwether cases in a multidistrict litigation over claims that they fueled a youth addiction epidemic.
Altria could soon have cash to burn. The $87 billion purveyor of Marlboro cigarettes is selling a wine business for $1.2 billion to focus on smokes. But the company run by Billy Gifford still has a $13 billion chunk of Anheuser-Busch Inbev, which it inherited from the sale...
Altria Group Inc said on Friday it would sell its Ste. Michelle Wine Estates business to private equity firm Sycamore Partners for $1.2 billion, as the tobacco giant looks to focus its business on cigarette alternatives for smokers.
Tobacco giant Altria Group Inc said on Friday it would sell its Ste. Michelle Wine Estates business to private equity firm Sycamore Partners Management for $1.2 billion. (Reporting by Uday Sampath in Bengaluru; Editing by Arun Koyyur)
Plaintiffs in a multidistrict litigation accusing Juul Labs Inc and its largest shareholder Altria Group Inc of fueling youth vaping addiction can depose Altria CEO William Gifford, a federal judge has ruled.
By Brendan Pierson Juul Labs Inc's co-founders, three of its directors and major stakeholder Altria Group have lost a bid to dismiss federal racketeering claims against them in a multidistrict litigation accusing them of fueling a youth vaping addiction.
Altria Group Inc general counsel Murray Garnick's total compensation hit $4.14 million in 2020 - a steep drop from his $7 million package in 2019.
U.S. District Judge Ketanji Brown Jackson in Washington on Monday expressed skepticism of two Altria Group units' bid for a preliminary injunction blocking a U.S. Food and Drug Administration rule requiring graphic health warning labels on cigarette packages, but said she...
Marlboro maker Altria Group Inc beat estimates for fourth-quarter revenue on Thursday and said it would invest a portion of profits from its booming cigarettes business into developing and marketing oral tobacco and heated tobacco products this year.
Altria Group Inc on Thursday forecast 2021 profit below estimates even as the Marlboro maker posted a 4.9% growth in net revenue in the fourth quarter on higher demand for smokeable tobacco products.
Altria Group Inc said on Thursday it would convert its non-voting shares in Juul Labs Inc to voting shares, days after the tobacco giant took another billion-dollar hit to its 35% stake in the e-cigarette maker.
Altria Group Inc <MO.N> on Friday took a third-quarter hit of $2.6 billion to its investment in Juul Labs Inc, further diminishing the value of its initial $12.8 billion stake in the e-cigarette maker that is facing increased regulatory scrutiny.
Altria Group Inc said on Friday it took a $2.6 billion charge on its investment in Juul Labs Inc in the third quarter, mainly due to lower revenue projection from the e-cigarette maker.
Juul Labs Inc has cut its valuation to about $10 billion from $12 billion at the end of last year, according to a company memo seen by Reuters on Thursday, as the once red-hot e-cigarette maker fizzles in a tumultuous period for the industry.
Marlboro maker Altria Group Inc <MO.N> said on Tuesday it expected full-year earnings to rise as much as 4% from last year and announced plans to make IQOS heated-tobacco devices available in more markets across the United States.
* GREENLIGHT CAPITAL INC TAKES SHARE STAKE OF 305,400 SHARES IN ALTRIA GROUP INC
Due to the COVID-19 pandemic, the Food and Drug Administration on Wednesday asked a federal judge to approve a delay of the effective date of a new rule requiring graphic health warnings on cigarette packages and in advertisements.
Altria Group Inc <MO.N> topped quarterly sales expectations as shoppers stocked up cigarettes ahead of COVID-19 lockdowns and the Marlboro maker said it would continue paying dividend, sending shares up about 2% in early trading on Thursday.
Marlboro cigarettes maker Altria Group Inc abandoned its full-year earnings forecast, citing "uncertainty" related to the coronavirus pandemic, even as it reported a better-than-expected 13% rise in quarterly revenue on Thursday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.